The DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.
Mechanisms of Anemia in CKD
Open accessAbstract
Anemia is a common feature of CKD associated with poor outcomes. The current management of patients with anemia in CKD is controversial, with recent clinical trials demonstrating increased morbidity and mortality related to erythropoiesis stimulating agents. Here, we examine recent insights into the molecular mechanisms underlying anemia of CKD. These insights hold promise for the development of new diagnostic tests and therapies that directly target the pathophysiologic processes underlying this form of anemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elderly patients often have a chronic inflammatory status, 41 which contributes to multifactorial anaemia in such subjects 33 along with the negative effects of nutritional deficiency and impaired renal function on iron homeostasis and erythropoiesis. 42”
From Anaemia, iron status, and gender predict the outcome in patients with chronic heart failure (2020) · cites this paper as [42]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
Correction of anemia with epoetin alfa in chronic kidney disease
Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M., & Reddan, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065485 · Cited by 2,762
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
Pfeffer, M. A., Burdmann, E. A., Chen, C.-Y., Cooper, M. E., de Zeeuw, D., Eckardt, K.-U., Feyzi, J. M., Ivanovich, P., Kewalramani, R., Levey, A. S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907845 · Cited by 2,096
Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
Eschbach, J. W., Egrie, J. C., Downing, M. R., Browne, J. K., & Adamson, J. W. (1987) · New England Journal of Medicine · doi:10.1056/nejm198701083160203 · Cited by 2,005
Besarab, A., Bolton, W. K., Browne, J. K., Egrie, J. C., Nissenson, A. R., Okamoto, D. M., Schwab, S. J., & Goodkin, D. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390903 · Cited by 1,930
(2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.12.005 · Cited by 1,788
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697
Winearls, C., Pippard, M., Downing, M., Oliver, D., Reid, C., & Mary Cotes, P. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92192-6 · Cited by 1,401
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324
Cloning and expression of the human erythropoietin gene.
Lin, F. K., Suggs, S., Lin, C. H., Browne, J. K., Smalling, R., Egrie, J. C., Chen, K. K., Fox, G. M., Martin, F., & Stabinsky, Z. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.22.7580 · Cited by 1,134
Isolation and characterization of genomic and cDNA clones of human erythropoietin
Jacobs, K., Shoemaker, C., Rudersdorf, R., Neill, S. D., Kaufman, R. J., Mufson, A., Seehra, J., Jones, S. S., Hewick, R., Fritsch, E. F., et al. (1985) · Nature · doi:10.1038/313806a0 · Cited by 1,080
Purification of human erythropoietin.
Miyake, T., Kung, C. K., & Goldwasser, E. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)63387-9 · Cited by 886
Role of the kidney in erythropoiesis
JACOBSON, L. O., GOLDWASSER, E., FRIED, W., & PLZAK, L. (1957) · Nature · doi:10.1038/179633a0 · Cited by 862
(2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.03.010 · Cited by 829
Immunoassay for human serum hepcidin
Ganz, T., Olbina, G., Girelli, D., Nemeth, E., & Westerman, M. (2008) · Blood · doi:10.1182/blood-2008-02-139915 · Cited by 688
Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes
Szczech, L. A., Barnhart, H. X., Inrig, J. K., Reddan, D. N., Sapp, S., Califf, R. M., Patel, U. D., & Singh, A. K. (2008) · Kidney International · doi:10.1038/ki.2008.295 · Cited by 526
Erythropoietic response and outcomes in kidney disease and type 2 diabetes
Solomon, S. D., Uno, H., Lewis, E. F., Eckardt, K.-U., Lin, J., Burdmann, E. A., de Zeeuw, D., Ivanovich, P., Levey, A. S., Parfrey, P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005109 · Cited by 473
A randomized controlled study of iron supplementation in patients treated with erythropoietin
Macdougall, I. C., Tucker, B., Thompson, J., Tomson, C. R. V., Baker, L. R. I., & Raine, A. E. G. (1996) · Kidney International · doi:10.1038/ki.1996.487 · Cited by 417
The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin
Eschbach, J. W. (1989) · Kidney International · doi:10.1038/ki.1989.18 · Cited by 408
Parfrey, P. S., Foley, R. N., Wittreich, B. H., Sullivan, D. J., Zagari, M. J., & Frei, D. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004121039 · Cited by 373
Humoral Regulation of Red Cell Production
ERSLEV, A. (1953) · Blood · doi:10.1182/blood.v8.4.349.349 · Cited by 366
Cloning and expression of the hyman erythropoietin gene
Lin, F. (1985) · Medical Entomology and Zoology · Cited by 351
Hepcidin—A Potential Novel Biomarker for Iron Status in Chronic Kidney Disease
Zaritsky, J., Young, B., Wang, H.-J., Westerman, M., Olbina, G., Nemeth, E., Ganz, T., Rivera, S., Nissenson, A. R., & Salusky, I. B. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05931108 · Cited by 350
Bright, R. (1840) · PubMed Central · Cited by 328
Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease
Ashby, D. R., Gale, D. P., Busbridge, M., Murphy, K. G., Duncan, N. D., Cairns, T. D., Taube, D. H., Bloom, S. R., Tam, F. W. K., Chapman, R. S., et al. (2009) · Kidney International · doi:10.1038/ki.2009.21 · Cited by 311
Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency
McGonigle, R. J. S., Wallin, J. D., Shadduck, R. K., & Fisher, J. W. (1984) · Kidney International · doi:10.1038/ki.1984.36 · Cited by 288
Sasu, B. J., Cooke, K. S., Arvedson, T. L., Plewa, C., Ellison, A. R., Sheng, J., Winters, A., Juan, T., Li, H., Begley, C. G., et al. (2010) · Blood · doi:10.1182/blood-2009-09-245977 · Cited by 251
Erythropoiesis in Patients with Renal Failure Undergoing Chronic Dialysis
Eschbach, J. W., Funk, D., Adamson, J., Kuhn, I., Scribner, B. H., & Finch, C. A. (1967) · New England Journal of Medicine · doi:10.1056/nejm196703232761202 · Cited by 247
Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD
Babitt, J. L., & Lin, H. Y. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.12.030 · Cited by 235
Self-citationRadioimmunoassay of erythropoietin: circulating levels in normal and polycythemic human beings.
Garcia, J. F., Ebbe, S., Hollander, L., Cutting, H. O., Miller, M. E., & Cronkite, E. P. (1982) · PubMed · Cited by 192
Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats
Theurl, I., Schroll, A., Sonnweber, T., Nairz, M., Theurl, M., Willenbacher, W., Eller, K., Wolf, D., Seifert, M., Sun, C. C., et al. (2011) · Blood · doi:10.1182/blood-2011-03-345066 · Cited by 189
Self-citationSun, C. C., Vaja, V., Babitt, J. L., & Lin, H. Y. (2012) · American Journal of Hematology · doi:10.1002/ajh.23110 · Cited by 185
Self-citationKroot, J. J. C., Kemna, E. H. J. M., Bansal, S. S., Busbridge, M., Campostrini, N., Girelli, D., Hider, R. C., Koliaraki, V., Mamalaki, A., Olbina, G., et al. (2009) · Haematologica · doi:10.3324/haematol.2009.010322 · Cited by 177
Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation
Steinbicker, A. U., Sachidanandan, C., Vonner, A. J., Yusuf, R. Z., Deng, D. Y., Lai, C. S., Rauwerdink, K. M., Winn, J. C., Saez, B., Cook, C. M., et al. (2011) · Blood · doi:10.1182/blood-2010-10-313064 · Cited by 173
Red Blood Cell Survival in Long-term Dialysis Patients
Vos, F. E., Schollum, J. B., Coulter, C. V., Doyle, T. C. A., Duffull, S. B., & Walker, R. J. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.03.031 · Cited by 158
I. EVIDENCE FOR THE VALIDITY OF THE ASSAY METHOD AND THE PHYSIOLOGICAL RELEVANCE OF ESTIMATES
Cotes, P. M. (1982) · British Journal of Haematology · doi:10.1111/j.1365-2141.1982.tb01938.x · Cited by 140
Correction of Uremic Iron Deficiency Anemia in Hemodialyzed Patients: A Prospective Study
Fudin, R., Jaichenko, J., Shostak, A., Bennett, M., & Gotloib, L. (1998) · The Nephron journals/Nephron journals · doi:10.1159/000045053 · Cited by 109
Markowitz, G. S., Ga, K., Re, F., Coco, M., & Ri, L. (1997) · PubMed · Cited by 96
The Heterogeneity of Circulating Human Serum Erythropoietin*
Sherwood, J. B., Carmichael, L., & Goldwasser, E. (1988) · Endocrinology · doi:10.1210/endo-122-4-1472 · Cited by 43
Bennett, C. L., Becker, P. S., Kraut, E. H., Samaras, A. T., & West, D. P. (2008) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2008.00524.x · Cited by 22
An immunological cross‐reactant of erythropoietin in serum which may invalidate EPO radioimmunoassay
Cotes, P. M., Tam, R. C., Reed, P., & Hellebostad, M. (1989) · British Journal of Haematology · doi:10.1111/j.1365-2141.1989.tb00263.x · Cited by 18
Ajuria, J. L., Kimmel, P. L., & Siegel, R. S. (2005) · CRC Press eBooks · doi:10.1201/b14192-28 · Cited by 11
Cited by
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Thomas, M. C., Brownlee, M., Susztak, K., Sharma, K., Jandeleit-Dahm, K. A. M., Zoungas, S., Rossing, P., Groop, P.-H., & Cooper, M. E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.18 · Cited by 1,230
Regulation of erythropoiesis by hypoxia-inducible factors
Haase, V. H. (2013) · Blood Reviews · doi:10.1016/j.blre.2012.12.003 · Cited by 787
“and may therefore be superior to the administration of recombinant EPO alone, especially in renal anemia patients, who often suffer from chronic inflammation, functional iron deficiency and EPO resistance.(243) The beneficial effects on ironmetabolism aremost likely producedwith”
BackgroundRoxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis
Chen, N., Hao, C., Liu, B.-C., Lin, H., Wang, C., Xing, C., Liang, X., Jiang, G., Liu, Z., Li, X., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1901713 · Cited by 621
Self-citationInflammation and functional iron deficiency regulate fibroblast growth factor 23 production
David, V., Martin, A., Isakova, T., Spaulding, C., Qi, L., Ramirez, V., Zumbrennen-Bullough, K. B., Sun, C. C., Lin, H. Y., Babitt, J. L., et al. (2016) · Kidney International · doi:10.1038/ki.2015.290 · Cited by 494
Self-citation
Metadata
- Authors
- Babitt, J. L., & Lin, H. Y.
- Affiliations
- Harvard University (US)
- Corresponding author
- Babitt, Jodie L.
- Lin, Herbert Y.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2012-10
- Volume
- 23
- Issue
- 10
- Pages
- 1631-1634
- ISSN
- 1046-6673 (ISSN-L)
- PMC
- PMC3458456
- OpenAlex
- W2098124630
- Cited by
- 1,041
- References
- 45
- Citations by year
- 2026: 77 · 2025: 93 · 2024: 107 · 2023: 107 · 2022: 116 · 2021: 148 · 2020: 113 · 2019: 73 · 2018: 63 · 2017: 55 · 2016: 36 · 2015: 21 · 2014: 24 · 2013: 8
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK-01837, K08DK075846, R01DK071837, R01DK069533, R01DK087727)
- Topics
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Keywords
- anemia of chronic kidney disease, molecular mechanisms, erythropoiesis-stimulating agents, anemia management, diagnostic testing, therapeutic target, morbidity and mortality
- MeSH terms
- Anemia, Erythropoiesis, Erythropoietin, Homeostasis, Humans, Models, Biological, Anemia, Iron-Deficiency, Iron, Dietary, Antimicrobial Cationic Peptides, Renal Insufficiency, Chronic, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.